Non-radiographic Axial Spondyloarthritis
·MeSH: Non-Radiographic Axial Spondyloarthritis
Prevalence
310.0 / 100K
Incidence
7.3 / 100K/yr
2 drugs in development·1 company·2 clinical trials
Drug Pipeline by Phase
Approved(2)
Frequently asked questions
How many drugs are in development for Non-radiographic Axial Spondyloarthritis?
BioSniper tracks 2 drugs in development for Non-radiographic Axial Spondyloarthritis across 1 company.
How many clinical trials target Non-radiographic Axial Spondyloarthritis?
There are 2 clinical trials targeting Non-radiographic Axial Spondyloarthritis tracked by BioSniper.
What is the prevalence of Non-radiographic Axial Spondyloarthritis?
The estimated prevalence of Non-radiographic Axial Spondyloarthritis is approximately 310.0 per 100,000 population.
Deep-dive into Non-radiographic Axial Spondyloarthritis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis